Does hSP90 inhibition by 17-DMAG attenuate oxidative stress in experimental atherosclerosis?
Our results suggest that HSP90 inhibitors interfere with oxidative stress and modulate experimental atherosclerosis development through reduction in pro-oxidative factors.
Our findings suggest that administration of BD after a negative MCT enhances the diagnostic accuracy of the challenge test as it identifies subjects who are likely to develop clinical asthma in the future.